Discover open access scientific publications

Systemic Interleukin-2 and Adoptive Transfer of Lymphokine-Activated Killer Cells Improves Antibody-Dependent Cellular Cytotoxicity in Patients With Relapsed B-Cell Lymphoma Treated With Rituximab